Skye Bioscience Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.88

+0.01 (+1.60%)

As of May 16, 2:25 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 79%

Hold 3 21%

Sell 0 0%

Price Target

Analyst Price Target +1,714.0% upside

Low Target $11.92

Average Target $15.90

High Target $19.90

Current Price $0.88

Current
$0.88

Target
$15.90

$11.92 $15.90 avg $19.90

Scenario Analysis

Bear Case

$11.92

1,260.0%

Low target

Base Case

$15.90

+1,714.0%

Avg target

Bull Case

$19.90

+2,170.4%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$5.75

-84.8% from high

52-Week Low

$0.57

+54.9% from low

Target vs 52W High

$15.90

+176.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%